However, only one small retrospective study had shown that adding liraglutide to insulin therapy resulted in a significant improvement in glycemic control, reduction in insulin requirement, and reduction of body weight without significant hypoglycemia [18]. The gene discussed is INS; the disease is Hypoglycemia.